Warren Nighan Joins Haemonetics as VP Worldwide Quality & Regulatory Affairs
BRAINTREE, Mass., Nov. 17, 2010 /PRNewswire-FirstCall/ -- Haemonetics Corporation (NYSE: HAE) announced today the hire of Warren Nighan as Vice President of Worldwide Quality & Regulatory Affairs, who will join the Company's Executive Council.
Mr. Nighan, age 41, most recently served as Vice President Quality & Regulatory for St. Jude Medical in Minneapolis, Minnesota. Prior to that, he held numerous roles of increasing responsibility in quality and regulatory affairs, at Covidien, Tyco Medical and Kendall Healthcare.
Mr. Nighan holds a bachelors degree in nursing from Northeastern University.
Brian Concannon , Haemonetics' President and CEO said, "It is a great compliment to Haemonetics to have attracted a quality and regulatory executive of Warren's stature and experience. Our company's dedication to a culture of quality and compliance is closely aligned with our vision to be the global provider of blood management solutions for our customers who meet the daily transfusion needs of millions of patients around the world. We all welcome Warren back to New England."
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.
Tel. (781) 356-9613
SOURCE Haemonetics Corporation
More by this Source
Haemonetics Reports 4th Quarter Fiscal 2013 Revenue Up 34% and Adjusted EPS of $0.48; Fourth Quarter and Full Year Organic Revenue Up 4% and Full Year Adjusted EPS of $1.71; Completes Hemerus Medical, LLC Acquisition and Provides Fiscal 2014 Guidanc
May 01, 2013, 07:00 ET
Haemonetics Completes Hemerus Medical, LLC Acquisition
May 01, 2013, 06:59 ET
Haemonetics Sets Date for Investor/Analyst Meeting
Apr 24, 2013, 08:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.